World's Best Scientists 2026 revealed!
Solbritt Rantapää-Dahlqvist

Solbritt Rantapää-Dahlqvist

D-Index & Metrics

Immunology

D-Index
88
Citations
32785
World Ranking
1154
National Ranking
20

Medicine

D-Index
89
Citations
32993
World Ranking
12577
National Ranking
238

Solbritt Rantapää-Dahlqvist publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Solbritt Rantapää-Dahlqvist sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 446 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Solbritt Rantapää-Dahlqvist D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Solbritt Rantapää-Dahlqvist sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Solbritt Rantapää-Dahlqvist is affiliated with Umeå University in Sweden and has a substantial body of work concentrated in the field of medicine, particularly within rheumatology. Their research encompasses genetics and immunology, with additional efforts focused on pulmonary and respiratory medicine, as well as radiology, nuclear medicine, and imaging.

Their research topics reflect a strong focus on autoimmune and inflammatory diseases. Principal topics include:

  • Systemic Lupus Erythematosus Research
  • Rheumatoid Arthritis Research and Therapies
  • Vasculitis and related conditions
  • Monoclonal and Polyclonal Antibodies Research
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Chronic Lymphocytic Leukemia Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Their recent publications demonstrate an emphasis on genetic mechanisms and molecular pathways linked to rheumatic diseases. Notable recent papers include:

  • Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis, 2022, Nature Genetics
  • Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing, 2020, Annals of the Rheumatic Diseases
  • Oral Microbiota Identifies Patients in Early Onset Rheumatoid Arthritis, 2021, Microorganisms
  • IgG Anti-Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross-Sectional Study Encompassing ~1,500 Samples, 2022, Arthritis & Rheumatology
  • Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases, 2022, Arthritis & Rheumatology

Coauthors frequently collaborating with Solbritt Rantapää-Dahlqvist include:

  • Lars Rönnblom
  • Andreas Jönsen
  • Christopher Sjöwall
  • Dag Leonard
  • Johanna K. Sandling

Their work has been published repeatedly in journals central to the field, such as:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Arthritis & Rheumatology
  • RMD Open
  • Scandinavian Journal of Rheumatology

Best Publications

  • Genetics of rheumatoid arthritis contributes to biology and drug discovery

    Yukinori Okada;Yukinori Okada;Di Wu;Di Wu;Di Wu;Gosia Trynka;Gosia Trynka;Towfique Raj;Towfique Raj

  • Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

    Solbritt Rantapää-Dahlqvist;Ben A. W. de Jong;Ewa Berglin;Göran Hallmans

  • A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.

    Lars Klareskog;Patrik Stolt;Karin Lundberg;Henrik Källberg

  • Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

    Geoffrey Hom;Robert R. Graham;Barmak Modrek;Kimberly E. Taylor

  • A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus

    Vesela Gateva;Johanna K. Sandling;Geoff Hom;Kimberly E. Taylor

  • High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis

    Steve Eyre;John Bowes;John Bowes;Dorothée Diogo;Dorothée Diogo;Annette Lee

  • Polymorphisms in the Tyrosine Kinase 2 and Interferon Regulatory Factor 5 Genes Are Associated with Systemic Lupus Erythematosus

    Snaevar Sigurdsson;Gunnel Nordmark;Harald H.H. Göring;Katarina Lindroos

  • Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

    J Askling;C M Fored;Eva Baecklund;L Brandt

  • Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.

    Solveig Wållberg-Jonsson;Helene Johansson;Marie-Louise Öhman;Solbritt Rantapää-Dahlqvist

  • Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis

    Heidi Kokkonen;Ingegerd Söderström;Joacim Rocklöv;Göran Hallmans

  • Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.

    Johan Askling;C. Michael Fored;Lena Brandt;Eva Baecklund

  • EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

    Danielle M. Gerlag;Karim Raza;Lisa G M van Baarsen;Elisabeth Brouwer

  • Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

    J Askling;CM Fored;L Brandt;E Baecklund

  • Time‐dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

    Johan Askling;C Michael Fored;Lena Brandt;Eva Baecklund

  • Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

    Diane van der Woude;Solbritt Rantapää-Dahlqvist;Andreea Ioan-Facsinay;Carla Onnekink

  • Transancestral mapping and genetic load in systemic lupus erythematosus

    Carl D. Langefeld;Hannah C. Ainsworth;Deborah S. Cunninghame Graham;Jennifer A. Kelly

  • Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset

    Ewa Berglin;T Johansson;U Sundin;Erik Jidell

  • A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.

    Ewa Berglin;Leonid Padyukov;Ulf Sundin;Göran Hallmans

  • Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis

    Unknown

  • A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis

    Hanna W. van Steenbergen;Luis Rodríguez-Rodríguez;Ewa Berglin;Alexandra Zhernakova

  • Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

    Johan Askling;Eva Baecklund;F. Granath;P. Geborek

Frequent Co-Authors

Lars Klareskog
Lars Klareskog Karolinska Institute
Anders A. Bengtsson
Anders A. Bengtsson Lund University
Andreas Jönsen
Andreas Jönsen Lund University
Leonid Padyukov
Leonid Padyukov Karolinska Institute
Lars Rönnblom
Lars Rönnblom Uppsala University
Johan Askling
Johan Askling Karolinska Institute
Elisabet Svenungsson
Elisabet Svenungsson Karolinska University Hospital
Iva Gunnarsson
Iva Gunnarsson Karolinska University Hospital
Ann-Christine Syvänen
Ann-Christine Syvänen Uppsala University
Peter K. Gregersen
Peter K. Gregersen Feinstein Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing advanced nursing roles such as Psychiatric Mental Health Nurse Practitioner (PMHNP) can be a compelling pathway. Many students explore options through top online pmhnp programs, which emphasize strong clinical placements to enhance hands-on experience.

Affordability is also crucial, especially for online learning. Prospective students can find a variety of options by researching the cheapest pmhnp programs online that offer quality education without compromising on accreditation or course rigor.

Salaries for Doctor of Nursing Practice (DNP) holders vary across states and specialties. Understanding how much do dnp nurses make provides valuable insight for career planning and financial decisions after completing an advanced degree.

Additionally, nurses interested in expanding their scope can explore transitioning pathways, like moving from Family Nurse Practitioner (FNP) to Acute Care Nurse Practitioner (ACNP). Guidance on fnp to acnp transition is beneficial for adapting skills to specialized acute care environments.

Best Scientists Citing Solbritt Rantapää-Dahlqvist

Trending Scientists